INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides me...
U.S. stock night market volatility: FDA restarts review + rating upgrade, Capricor surges 58%
INKON Life announces its first cash dividend, distributing a cash dividend of 0.25 yuan for every 10 shares
INKON Life: Peng Wenci resigns as director and general manager, Ma Anjie succeeds as general manager
INKON Life: Acquisition of Changsha Kexin completed the industrial and commercial change registration
INKON Life released its first-quarter performance, with a net profit attributable to the parent company of 29.9927 million yuan, an increase of 14.36%
Fangsheng Pharmaceutical: Hunan Kexin plans to sell 51% of its subsidiary hospital Changsha Kexin